PRTN3 and rheumatoid arthritis: ACPA-positive and ACPA-negative patients may exhibit similar clinical manifestations at baseline, but different phenotypes with respect to subsequent radiographic progression.[34,35] Interestingly, in the present study there was a modest correlation between sTIM-3 concentration and MMP-3 in RA patients with advance joint damage (stage III or IV).